Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV.
Document Type
Journal Article
Publication Date
5-17-2019
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume
68
Issue
11
Inclusive Pages
1823-1830
DOI
10.1093/cid/ciy801
APA Citation
Evans, S., Tran, T., Hujer, A., Hill, C., Hujer, K., Mediavilla, J., Manca, C., Domitrovic, T., Perez, F., Farmer, M., Pitzer, K., Wilson, B., Kreiswirth, B., Patel, R., Jacobs, M., Chen, L., Fowler, V., Chambers, H., & Bonomo, R. (2019). Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68 (11). http://dx.doi.org/10.1093/cid/ciy801
Peer Reviewed
1